Timur Cerić
Prof. Dr. Timur Cerić is a specialist in Internal Medicine and Medical Oncology and an Associate Professor at the Faculty of Medicine, University of Sarajevo. He has built an extensive career in clinical oncology, academic medicine, scientific research, and international professional cooperation.
Dr. Cerić graduated from the Faculty of Medicine, University of Sarajevo, in 2001, with a thesis on chromosomal changes in acute leukemias. He subsequently completed postgraduate studies in the experimental-laboratory field, followed by specialization in Internal Medicine, which he completed in 2008. In 2009, he obtained a Master of Medical Sciences degree with research focused on the correlation between toxicity and specific genotypes of the dihydropyrimidine dehydrogenase enzyme during 5-fluorouracil therapy. He received his PhD in Medical Sciences in 2015, with a dissertation examining circulating tumor cells as prognostic and predictive markers in the treatment of breast cancer. In 2016, he completed his subspecialization in Medical Oncology.
His professional career has been closely associated with the Oncology Clinic of the Clinical Center University of Sarajevo. He joined the Institute of Oncology in 2002 and subsequently completed his residency in Internal Medicine there. Since 2008, he has worked as a specialist in Internal Medicine and Medical Oncology, with a focus on outpatient chemotherapy. Between 2015 and 2016, he served as Head of the Department for Palliative and Supportive Care. Since 2018, he has been Head of the Day Hospital Department at the Oncology Clinic of KCUS.
Alongside his clinical work, Prof. Dr. Cerić has developed a significant academic career at the Faculty of Medicine, University of Sarajevo. From 2010 to 2015, he served as a Senior Teaching Assistant in Oncology and Internal Medicine, before being appointed Assistant Professor in 2015. Since 2020, he has held the position of Associate Professor, contributing to teaching and academic activities in the fields of Oncology and Internal Medicine.
Prof. Dr. Cerić has participated in numerous international oncology congresses and seminars, including major European and American meetings organized by ESMO and ASCO. He became a member of the European Society for Medical Oncology (ESMO) in 2002 and an associate member of the American Association for Cancer Research (AACR) in 2005. He has also served as the national representative of Bosnia and Herzegovina in the Balkan Union of Oncology (BUON) and ESMO, and has participated in COST and European research initiatives focused on cancer research, including pancreatic cancer.
His professional and scientific engagement also includes membership in the Committee for Malignant Diseases of the Academy of Sciences and Arts of Bosnia and Herzegovina and previous service on the Ethics Committee of the Faculty of Medicine, University of Sarajevo. His international professional development includes a specialized European fellowship in multidisciplinary breast cancer care, with training at the Interdisciplinary Breast Center of Klinikum rechts der Isar, Technical University of Munich. He also completed further training in Medical Oncology at the Institute of Oncology in Ljubljana, Slovenia.
For his scientific and professional contributions, Prof. Dr. Cerić has received the Prof. Dr. Hiba Bašić Award from the Association of Oncologists of Bosnia and Herzegovina for a published scientific paper, as well as several acknowledgements for his contribution to medical education, professional initiatives, and healthcare-related projects.